Proto Labs (PRLB) Common Equity (2011 - 2026)

Proto Labs has disclosed Common Equity across 16 years of filings, most recently posting $683.1 million for Q1 2026.

• Common Equity for Q1 2026 came in at $683.1 million, up 4.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $683.1 million (up 4.01% YoY), and the FY2025 annual result was $673.9 million, up 0.56% from the prior year.
• Common Equity came in at $683.1 million for Q1 2026 at Proto Labs, up from $673.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $832.0 million in Q1 2022 to a low of $656.8 million in Q1 2025.
• The 5-year median for Common Equity is $683.1 million (2023), against an average of $704.3 million.
• Across the five-year window, Common Equity slipped 17.9% in 2023 and gained 4.01% in 2026, its largest moves.
• Proto Labs' Common Equity stood at $697.6 million in 2022, then slipped by 0.34% to $695.3 million in 2023, then declined by 3.62% to $670.2 million in 2024, then grew by 0.56% to $673.9 million in 2025, then rose by 1.36% to $683.1 million in 2026.
• The last three Common Equity figures came in at $683.1 million (Q1 2026), $673.9 million (Q4 2025), and $664.7 million (Q3 2025), per Business Quant data.